Cargando…
The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time
Vaccines to viral pathogens in experimental animal models are often deemed successful if immunization enhances resistance of the host to virus challenge as measured by cumulative survival, reduction in virus replication and spread and/or lessen or eliminate overt tissue pathology. Furthermore, the d...
Autores principales: | Carr, Daniel J. J., Berube, Amanda, Gershburg, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618588/ https://www.ncbi.nlm.nih.gov/pubmed/34832625 http://dx.doi.org/10.3390/pathogens10111470 |
Ejemplares similares
-
HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition
por: Gmyrek, Grzegorz B., et al.
Publicado: (2022) -
ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene
por: Liu, Mingyu, et al.
Publicado: (2010) -
A Live-Attenuated HSV-2 ICP0
(−) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
por: Halford, William P., et al.
Publicado: (2011) -
The HSV-1 ubiquitin ligase ICP0: Modifying the cellular proteome to promote infection
por: Rodríguez, Milagros Collados, et al.
Publicado: (2020) -
A quantitative assay to monitor HSV-1 ICP0 ubiquitin ligase activity in vitro
por: Boutell, Chris, et al.
Publicado: (2015)